ES2646737T3 - Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico - Google Patents

Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico Download PDF

Info

Publication number
ES2646737T3
ES2646737T3 ES12750597.2T ES12750597T ES2646737T3 ES 2646737 T3 ES2646737 T3 ES 2646737T3 ES 12750597 T ES12750597 T ES 12750597T ES 2646737 T3 ES2646737 T3 ES 2646737T3
Authority
ES
Spain
Prior art keywords
acid hydrochloride
therapeutic system
transdermal therapeutic
aminolevulinic acid
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12750597.2T
Other languages
English (en)
Inventor
Tobias Jung
Michael Horstmann
Gerd Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Photonamic GmbH and Co KG
Original Assignee
LTS Lohmann Therapie Systeme AG
Photonamic GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG, Photonamic GmbH and Co KG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2646737T3 publication Critical patent/ES2646737T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Sistema terapéutico transdérmico que comprende una capa de respaldo que es impermeable al principio activo, una matriz polimérica y una capa protectora desprendible caracterizado porque el principio activo es clorhidrato de ácido 5-aminolevulínico, porque el polímero de base de la matriz polimérica es un poliacrilato adhesivo y porque el poliacrilato ha sido obtenido sin agente de reticulación.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES12750597.2T 2011-08-31 2012-08-24 Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico Active ES2646737T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102011111865 2011-08-31
DE102011111865A DE102011111865A1 (de) 2011-08-31 2011-08-31 Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
PCT/EP2012/066541 WO2013030129A1 (de) 2011-08-31 2012-08-24 Transdermales therapeutisches system für 5-aminolävulinsäurehydrochlorid

Publications (1)

Publication Number Publication Date
ES2646737T3 true ES2646737T3 (es) 2017-12-15

Family

ID=46724447

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12750597.2T Active ES2646737T3 (es) 2011-08-31 2012-08-24 Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico

Country Status (17)

Country Link
US (2) US10307382B2 (es)
EP (1) EP2750673B1 (es)
JP (2) JP6035335B2 (es)
KR (1) KR101933610B1 (es)
CN (1) CN103764135B (es)
AU (1) AU2012301042B2 (es)
BR (1) BR112014004635B1 (es)
CA (1) CA2844288C (es)
DE (1) DE102011111865A1 (es)
DK (1) DK2750673T3 (es)
ES (1) ES2646737T3 (es)
MX (1) MX351514B (es)
NO (1) NO2750673T3 (es)
PL (1) PL2750673T3 (es)
PT (1) PT2750673T (es)
RU (1) RU2607657C2 (es)
WO (1) WO2013030129A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9179844B2 (en) 2011-11-28 2015-11-10 Aranz Healthcare Limited Handheld skin measuring or monitoring device
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
US10013527B2 (en) 2016-05-02 2018-07-03 Aranz Healthcare Limited Automatically assessing an anatomical surface feature and securely managing information related to the same
US11116407B2 (en) 2016-11-17 2021-09-14 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
EP3606410B1 (en) 2017-04-04 2022-11-02 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
KR102171200B1 (ko) 2018-11-20 2020-10-28 제너럴바이오(주) 5-아미노레불린산 수화염화물과 그 유도체를 유효성분으로 함유하는 여드름성 피부염 개선 또는 그의 조성물
CN111517973B (zh) * 2019-02-02 2023-08-04 中国科学院天津工业生物技术研究所 一种从发酵液中制备5-氨基乙酰丙酸盐酸盐的生产工艺及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
BR9709920A (pt) * 1996-06-20 2000-01-11 Lavipharm Sa Dispositivo para tratamento tópico da acne e seu método de manufatura
GR1002807B (el) 1996-06-20 1997-11-13 Lavipharm A.E. Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
US5856566A (en) 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
ES2237415T5 (es) * 1999-01-14 2008-12-16 Noven Pharmaceuticals, Inc. Composiciones dermicas.
DE10034673C1 (de) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
JP2004506005A (ja) * 2000-08-16 2004-02-26 ザ　ジェネラル　ホスピタル　コーポレイション　ディー　ビー　エイ　マサチューセッツ　ジェネラル　ホスピタル 尋常性挫瘡用の局所アミノレブリン酸−光力学的治療
KR100846912B1 (ko) 2001-01-12 2008-07-17 페데랄노에고수다르스트벤노에유니타르노에프레드프리야티에고수다르스트벤니나우쉬니티센트르나우쉬노이슬레도바텔스키인스티튜트오르가니쉐스키크흐포루프로두크토브아이크르아시텔에이에프지업지엔트스니오피크 광에너지 요법 및 그 요법을 수행하기 위한 도포기
DE60230796D1 (de) * 2001-10-24 2009-02-26 Power Paper Ltd Vorrichtung für die kontrollierte abgabe eines wirkstoffes in die haut
DE10200578A1 (de) 2002-01-09 2003-07-10 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme
DE10202487A1 (de) * 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
DE10344334A1 (de) 2003-09-24 2005-04-28 Johann Berger Gewebtes Gurtband
WO2006080199A1 (ja) 2005-01-31 2006-08-03 Hisamitsu Pharmaceutical Co., Inc. 貼付剤
US20060182790A1 (en) * 2005-02-17 2006-08-17 Flor Mayoral Dermal medicaments application enhancer
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient

Also Published As

Publication number Publication date
DK2750673T3 (da) 2017-11-20
CN103764135A (zh) 2014-04-30
US20140323994A1 (en) 2014-10-30
BR112014004635A2 (pt) 2017-03-14
PL2750673T3 (pl) 2018-11-30
RU2607657C2 (ru) 2017-01-10
PT2750673T (pt) 2017-11-15
RU2014111255A (ru) 2015-10-10
KR20140056370A (ko) 2014-05-09
JP2014527537A (ja) 2014-10-16
CA2844288C (en) 2019-08-20
EP2750673A1 (de) 2014-07-09
WO2013030129A1 (de) 2013-03-07
CA2844288A1 (en) 2013-03-07
MX351514B (es) 2017-10-17
AU2012301042A1 (en) 2014-03-20
JP6203364B2 (ja) 2017-09-27
DE102011111865A1 (de) 2013-02-28
EP2750673B1 (de) 2017-08-09
US20190240166A1 (en) 2019-08-08
JP2017061489A (ja) 2017-03-30
CN103764135B (zh) 2018-06-22
JP6035335B2 (ja) 2016-11-30
KR101933610B1 (ko) 2018-12-28
NO2750673T3 (es) 2018-01-06
BR112014004635B1 (pt) 2022-09-13
MX2014002215A (es) 2014-04-30
AU2012301042B2 (en) 2017-07-13
US10307382B2 (en) 2019-06-04

Similar Documents

Publication Publication Date Title
ES2646737T3 (es) Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico
ES2543977T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
ES2536206T3 (es) Parche medicinal
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2471951T3 (es) Procedimiento y dispositivo para el estampado en caliente
ES2649340T3 (es) Administración de fármacos activados por hipoxia y agentes antiangiogénicos para el tratamiento del cáncer
ES2523727T3 (es) Procedimiento y dispositivo para producir parche adhesivo
ES2496092T3 (es) El uso de amisulprida para tratar náuseas y vómitos posoperatorios
ES2409069B2 (es) Uso de aglutinantes para fabricar formulaciones estables al almacenamiento
ES2529464T3 (es) Lámina o cinta adhesiva sensible a la presión para aplicación cutánea y proceso para producir la misma
PE20151147A1 (es) Sistema de liberacion transdermica
ES2513691T3 (es) Preparación transdérmica
CL2011000935A1 (es) Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor.
AR088232A1 (es) Composiciones farmaceuticas
ES2486615A2 (es) Formulación, resina o extruido para conformar una estructura celular aislante, polimérica y no aromática, artículo y material que se obtiene, recipiente conformado y proceso de obtención.
CL2012003281A1 (es) Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica.
AR096521A1 (es) Sistema de liberación transdérmico, uso, método de fabricación
CY1116638T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας
CL2012002909A1 (es) Procedimiento de preparación de una composición farmacéutica que comprenden a) un centro granulado constituido por granos de principio activo aglomerados en presencia de aglomerante y b) una capa de recubrimiento de dicho centro granulado constituido por matriz grasa; composición farmacéutica; y su uso para administración oral
RU2016109449A (ru) Устройства для трансдермальной доставки дексмедетомидина и способы их применения
CL2009001556A1 (es) Sistema de administración transdermica de fármacos que comprende una capa que contiene fármaco que comprende una matriz polimérica que contiene estradiol como unico fármaco; método de elaboración; útil para administrar estradiol.
CL2013000477A1 (es) Formulacion farmaceutica oral de liberacion inmediata que comprende nalbufina o una sal de la misma, y al menos, un soporte de granulacion hidrofilo, un aglutinante hidrofilo y un lubricante, util para el tratamiento del dolor y la dependencia a los opioides.
AR082640A1 (es) Un dispositivo para la administracion transdermal de compuestos alcalinos susceptibles a la degradacion en su forma no salificada
AR095672A1 (es) Composiciones farmacéuticas que comprenden everolimus
AR094289A1 (es) Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol